Furosemide 10 mg/ml Solution for Injection or Infusion

국가: 아일랜드

언어: 영어

출처: HPRA (Health Products Regulatory Authority)

유효 성분:

Furosemide

제공처:

Accord Healthcare Limited

ATC 코드:

C03CA; C03CA01

INN (International Name):

Furosemide

복용량:

10 milligram(s)/millilitre

약제 형태:

Solution for injection/infusion

처방전 유형:

Product subject to prescription which may not be renewed (A)

치료 영역:

Sulfonamides, plain; furosemide

승인 상태:

Marketed

승인 날짜:

2005-07-22

환자 정보 전단

PACKAGE LEAFLET: INFORMATION FOR THE USER
FUROSEMIDE 10 MG/ML SOLUTION FOR INJECTION OR INFUSION
FUROSEMIDE
The name of your medicine is ‘Furosemide 10 mg/ml Solution for
Injection or Infusion’ but in the rest
of the leaflet it will be called “Furosemide Injection 10 mg/ml”.
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects
not listed in this leaflet. See section 4.
-
WHAT IS IN THIS LEAFLET
1. What Furosemide Injection 10 mg/ml is and what it is used for
2. What you need to know before you use Furosemide Injection 10 mg/ml
3. How to use Furosemide Injection 10 mg/ml
4. Possible side effects
5. How to store Furosemide Injection 10 mg/ml
6. Contents of the pack and other information
1.
WHAT FUROSEMIDE INJECTION 10 MG/ML IS AND WHAT IT IS USED FOR
Furosemide Injection 10 mg/ml contains the active ingredient
furosemide.
Furosemide is one of a group of medicines called diuretics. Furosemide
works by helping to
produce more urine. This helps to relieve symptoms caused when your
body contains too much
fluid.
YOUR DOCTOR HAS PRESCRIBED FUROSEMIDE FOR ONE OF THE FOLLOWING
REASONS:
•When quick and effective removal of excess fluid is needed.
•You are not able to take this kind of medicine by mouth or in an
emergency.
•You have too much fluid around your heart, lungs, liver or kidneys.
• in periods with extremely high blood pressure that may lead to
life-threatening conditions
(hypertensive crisis)
FUROSEMIDE INJECTION MUST ONLY BE USED UNDER MEDICAL SUPERVISION.
2.
WHAT YOU NEED TO KNOW BEFORE YOU USE FUROSEMIDE INJECTION 10 MG/ML
DO NOT USE FUROSEMIDE INJECTION 10 MG/

제품 특성 요약

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Furosemide 10 mg/ml Solution for Injection or Infusion
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 1 ml of solution contains 10 mg Furosemide.
Each 2 ml ampoule contains 20 mg Furosemide (20mg/2ml).
Each 4 ml ampoule contains 40 mg Furosemide (40mg/4ml).
Each 5 ml ampoule contains 50 mg Furosemide (50mg/5ml).
Each 25 ml vial contains 250 mg Furosemide (250mg/25ml).
Excipients:
Each 2 ml of sterile solution contains approximately 7 mg of sodium.
Each 4 ml of sterile solution contains approximately 15 mg of sodium.
Each 5 ml of sterile solution contains approximately 19 mg of sodium.
Each 25 ml of sterile solution contains approximately 93 mg of sodium.
For the full list of excipients see section 6.1
3 PHARMACEUTICAL FORM
Solution for injection or infusion.
Clear, colourless or almost colourless solution (pH: 8.0 to 9.3).
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
When a prompt diuresis is required. Use in emergencies or when oral
therapy is precluded. Indications include:
_- Oedema and/or ascites caused by cardiac or hepatic diseases_
-_ Oedema caused by renal diseases (in case of nephrotic syndrome,
treatment of the underlying disease is_
_essential)_
_- Pulmonary oedema (e.g. in case of acute heart failure)_
-_ Hypertensive crisis (in addition to other therapeutic measures)_
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration: intravenous or (in exceptional cases)
intramuscular
General:
The parenteral
administration of
furosemide is indicated in cases where oral
administration is not
feasible or
not
efficient (for example in case of reduced intestinal absorption) or
when a quick effect is required. To achieve optimum
efficacy and suppress counter-regulation,
a continuous furosemide infusion is generally to be preferred to
repeated
bolus injections.
Consideration should be given to current clinical guidelines where
available.
Where continuous furosemide infusion is not feasible for follow-up
treatment after one or several